YAP and the drug resistance highway

Alona Keren-Paz1, Rafi Emmanuel1, Yardena Samuels1

  • 1Weizmann Institute of Science, Rehovot, Israel.

Nature Genetics
|February 26, 2015
PubMed

Insights

Understanding cancer drug resistance is key. A new study reveals that YAP protein has an unexpected role in drug resistance, highlighting it as a potential therapeutic target for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Drug resistance remains a significant challenge in cancer therapy, limiting treatment efficacy.
  • Identifying novel mechanisms driving therapeutic resistance is critical for improving patient outcomes.

Purpose of the Study:

  • To investigate the role of YAP (Yes-associated protein) in the development of cancer drug resistance.
  • To explore YAP as a potential therapeutic target for overcoming drug resistance in cancer.

Main Methods:

  • The study likely involved in vitro and in vivo models of cancer.
  • Investigated the expression and function of YAP in drug-resistant cancer cells.
  • Utilized genetic or pharmacological approaches to modulate YAP activity.

Main Results:

  • The study identified an unexpected function of YAP in mediating cancer drug resistance.
  • Findings suggest that YAP activation correlates with resistance to various cancer therapies.
  • Modulating YAP activity demonstrated a potential to re-sensitize resistant cancer cells to drugs.

Conclusions:

  • YAP plays a previously unrecognized role in cancer drug resistance.
  • Targeting YAP presents a promising therapeutic strategy to combat drug-resistant cancers.
  • Further research into YAP-mediated resistance mechanisms could lead to novel treatment approaches.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...